Search for: "Hyman Phelps McNamara"
Results 61 - 80
of 232
Sorted by Relevance
|
Sort by Date
21 Jan 2011, 6:39 am
The program, titled “The Economics of Orphan Drugs – Why Successful Cures Bring Challenges for Patients and Payment,” will be posted on the internet here, and featues Peter Saltonstall, President & CEO of the National Organization for Rare Disorders, Frank Sasinowski, Chairman of the Board at NORD (and Hyman, Phelps & McNamara, P.C. [read post]
5 Jun 2012, 5:54 pm
Hyman, Phelps & McNamara, P.C. [read post]
20 Aug 2012, 1:33 am
Hyman, Phelps & McNamara, P.C. [read post]
19 Jan 2012, 7:44 pm
Hyman, Phelps & McNamara, P.C. [read post]
10 Dec 2010, 9:01 am
In August 2008, at the Democratic National Convention in Denver, Hyman, Phelps & McNamara’s Frank Sasinowski, the current chairman of the National Organization of Rare Diseases ("NORD"), had the idea to start a Congressional caucus on rare and neglected diseases in order to have a forum for issues that matter to the more than 25 million Americans with rare or orphan disorders. [read post]
11 May 2011, 1:27 pm
Hyman, Phelps & McNamara, P.C., Director Josephine M. [read post]
12 Dec 2010, 9:11 am
At a December 8th retirement party, her contributions were recognized by almost all of the nine chief counsels with whom she worked (including Hyman, Phelps & McNamara’s Tom Scarlett), and she received the Distinguished Career Service Award from the FDA Commissioner and a Certificate of Appreciation from the HHS Secretary. [read post]
4 Jun 2012, 4:51 pm
Hyman, Phelps & McNamara, P.C. [read post]
8 Aug 2012, 4:22 pm
Hyman, Phelps & McNamara, P.C. is pleased to announce that Anne Walsh will moderate a panel on “Trends and Priorities in Enforcement” at this year’s Food and Drug Law Institute’s (“FDLI”) Advertising and Promotion Conference. [read post]
10 May 2012, 3:26 pm
Hyman, Phelps & McNamara P.C. invites you to register for our webinar, “Garbage Runs, Fake Identities, and Surprise Home Visits: Strategies to Deal With FDA's Nontraditional Investigative Tools,” which is scheduled to take place on Wednesday, June 20, 2012 from 12:30 - 2:00 p.m. [read post]
17 Jun 2012, 5:17 am
Hyman, Phelps & McNamara P.C. invites you to register for our webinar, “Garbage Runs, Fake Identities, and Surprise Home Visits: Strategies to Deal With FDA's Nontraditional Investigative Tools,” which is scheduled to take place on Wednesday, June 20, 2012 from 12:30 - 2:00 p.m. [read post]
22 Mar 2011, 9:04 am
Hyman, Phelps & McNamara, P.C. [read post]
19 Jan 2012, 7:46 pm
On March 21, 2012 (12:30 - 2:00 PM ET), Hyman, Phelps & McNamara, P.C. will host a free webinar, titled “FDA Appeals - Improving Your Odds of Success; Trends, Expectations, Strategies. [read post]
4 Jan 2011, 1:45 pm
Hyman, Phelps & McNamara, P.C. [read post]
9 Jan 2025, 6:48 pm
Walsh & Hyman, Phelps & McNamara, P.C. [read post]
15 Apr 2010, 11:42 am
The March/April 2010 issue of FDLI Update contains an article by Hyman, Phelps & McNamara, P.C. [read post]
20 Jun 2012, 6:17 pm
Hyman, Phelps & McNamara, P.C. [read post]
13 Mar 2011, 4:45 pm
By Peter M. [read post]
28 Apr 2015, 9:14 am
Karst runs the excellent FDA Law Blog and is also a director at Hyman, Phelps & McNamara. [read post]
5 Feb 2024, 6:40 pm
HP&M has been helping clients navigate the challenges of state licensing regulations for drugs, biologics, medical devices, OTCs, 503B outsourcing facilities, 503A pharmacies, foods, dietary supplements, cannabis, and wholesalers/distributors for many years. [read post]
